10x Genomics Stock Price Patterns
| TXG Stock | USD 18.12 0.61 3.48% |
Momentum 50
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.17) | EPS Estimate Current Year (1.04) | EPS Estimate Next Year (0.11) | Wall Street Target Price 18.8462 | EPS Estimate Current Quarter (0.04) |
Using 10X Genomics hype-based prediction, you can estimate the value of 10X Genomics from the perspective of 10X Genomics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards 10X Genomics using 10X Genomics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards 10X using crowd psychology based on the activity and movement of 10X Genomics' stock price.
10X Genomics Short Interest
A significant increase or decrease in 10X Genomics' short interest from the previous month could be a good indicator of investor sentiment towards 10X. Short interest can provide insight into the potential direction of 10X Genomics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 13.9802 | Short Percent 0.2049 | Short Ratio 6.3 | Shares Short Prior Month 16.3 M | 50 Day MA 18.6722 |
10X Genomics Hype to Price Pattern
Investor biases related to 10X Genomics' public news can be used to forecast risks associated with an investment in 10X. The trend in average sentiment can be used to explain how an investor holding 10X can time the market purely based on public headlines and social activities around 10X Genomics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of 10X Genomics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about 10X Genomics.
10X Genomics Implied Volatility | 1.12 |
10X Genomics' implied volatility exposes the market's sentiment of 10X Genomics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if 10X Genomics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that 10X Genomics stock will not fluctuate a lot when 10X Genomics' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in 10X Genomics to buy its stock at a price that has no basis in reality. In that case, they are not buying 10X because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
10X Genomics after-hype prediction price | USD 18.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current 10X contract
Based on the Rule 16, the options market is currently suggesting that 10X Genomics will have an average daily up or down price movement of about 0.07% per day over the life of the 2026-05-15 option contract. With 10X Genomics trading at USD 18.12, that is roughly USD 0.0127 . If you think that the market is fully incorporating 10X Genomics' daily price movement you should consider acquiring 10X Genomics options at the current volatility level of 1.12%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out 10X Genomics Basic Forecasting Models to cross-verify your projections. Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 10X Genomics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
10X Genomics After-Hype Price Density Analysis
As far as predicting the price of 10X Genomics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in 10X Genomics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of 10X Genomics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
10X Genomics Estimiated After-Hype Price Volatility
In the context of predicting 10X Genomics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on 10X Genomics' historical news coverage. 10X Genomics' after-hype downside and upside margins for the prediction period are 14.21 and 22.21, respectively. We have considered 10X Genomics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
10X Genomics is not too volatile at this time. Analysis and calculation of next after-hype price of 10X Genomics is based on 3 months time horizon.
10X Genomics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as 10X Genomics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading 10X Genomics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with 10X Genomics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.31 | 4.00 | 0.09 | 0.10 | 9 Events / Month | 7 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
18.12 | 18.21 | 0.50 |
|
10X Genomics Hype Timeline
On the 15th of February 2026 10X Genomics is traded for 18.12. The entity has historical hype elasticity of 0.09, and average elasticity to hype of competition of 0.1. 10X is anticipated to increase in value after the next headline, with the price projected to jump to 18.21 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 0.5%, whereas the daily expected return is at this time at 0.31%. The volatility of related hype on 10X Genomics is about 1238.39%, with the expected price after the next announcement by competition of 18.22. The company reported the last year's revenue of 642.82 M. Reported Net Loss for the year was (43.54 M) with profit before taxes, overhead, and interest of 442.49 M. Considering the 90-day investment horizon the next anticipated press release will be in about 9 days. Check out 10X Genomics Basic Forecasting Models to cross-verify your projections.10X Genomics Related Hype Analysis
Having access to credible news sources related to 10X Genomics' direct competition is more important than ever and may enhance your ability to predict 10X Genomics' future price movements. Getting to know how 10X Genomics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how 10X Genomics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SDGR | Schrodinger | 0.13 | 8 per month | 0.00 | (0.23) | 3.89 | (5.25) | 21.90 | |
| PGNY | Progyny | (0.26) | 10 per month | 0.00 | (0.08) | 3.57 | (4.17) | 20.44 | |
| GRDN | Guardian Pharmacy Services | (0.22) | 10 per month | 2.47 | 0.05 | 4.77 | (3.83) | 13.96 | |
| TDOC | Teladoc | (0.37) | 10 per month | 0.00 | (0.25) | 4.03 | (5.35) | 15.93 | |
| OMDA | Omada Health Common | 0.48 | 9 per month | 0.00 | (0.23) | 4.61 | (10.52) | 19.12 | |
| JANX | Janux Therapeutics | 0.03 | 7 per month | 0.00 | (0.10) | 7.88 | (5.07) | 63.52 | |
| OMCL | Omnicell | (1.55) | 8 per month | 3.59 | (0.01) | 6.48 | (4.34) | 23.86 | |
| SION | Sionna Therapeutics Common | 5.07 | 7 per month | 5.47 | 0.03 | 7.92 | (8.89) | 31.39 | |
| NUVB | Nuvation Bio | (0.33) | 9 per month | 4.41 | 0.07 | 7.33 | (5.41) | 68.61 | |
| CERT | Certara | 0.25 | 8 per month | 0.00 | (0.16) | 4.75 | (5.06) | 14.22 |
10X Genomics Additional Predictive Modules
Most predictive techniques to examine 10X price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for 10X using various technical indicators. When you analyze 10X charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About 10X Genomics Predictive Indicators
The successful prediction of 10X Genomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as 10X Genomics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of 10X Genomics based on analysis of 10X Genomics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to 10X Genomics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to 10X Genomics's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 13.31 | 15.21 | 15.62 | 16.41 | Days Of Inventory On Hand | 128.47 | 154.53 | 103.37 | 131.91 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Complementary Tools for 10X Stock analysis
When running 10X Genomics' price analysis, check to measure 10X Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 10X Genomics is operating at the current time. Most of 10X Genomics' value examination focuses on studying past and present price action to predict the probability of 10X Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 10X Genomics' price. Additionally, you may evaluate how the addition of 10X Genomics to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |